Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Follicular lymphoma: grounds for optimism

T A Lister1

  • 1ICRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|January 1, 1997
PubMed
Summary

Follicular lymphoma has unique molecular markers and immune characteristics. These features enable the development of new curative therapies and hypothesis testing for treatment optimization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969-1999.

Hematology (Amsterdam, Netherlands)·2016
Same author

Life expectancy of young adults with follicular lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors.

British journal of cancer·2013
Same author

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.

Leukemia·2012
Same author

Frequency of leukemic initiating cells does not depend on the xenotransplantation model used.

Leukemia·2011
Same author

An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b.

Nature·2009

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Follicular lymphoma is a specific type of non-Hodgkin lymphoma.
  • It exhibits a distinct immune phenotype and a characteristic chromosomal translocation.
  • These features are detectable at the molecular level.

Purpose of the Study:

  • To review current therapeutic strategies for follicular lymphoma.
  • To explore the potential of molecular markers in designing novel curative therapies.
  • To discuss optimism surrounding advancements in follicular lymphoma treatment.

Main Methods:

  • Review of existing literature on follicular lymphoma.
  • Analysis of molecular and immunological characteristics.
  • Evaluation of current and emerging therapeutic approaches.

Main Results:

  • Specific immune phenotype and chromosomal translocations are key identifiers.
  • Molecular detection enables hypothesis testing for treatment efficacy.
  • Advancements in understanding offer optimism for curative strategies.

Conclusions:

  • The specific molecular and immune profile of follicular lymphoma is crucial.
  • Novel therapeutic strategies can be designed based on these characteristics.
  • Further research holds promise for curative treatment of follicular lymphoma.

Related Experiment Videos